KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Shares Issued (2017 - 2025)

Guardant Health (GH) has disclosed Shares Issued for 9 consecutive years, with $11.5 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 156.11% to $11.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.2 million through Dec 2025, up 64.03% year-over-year, with the annual reading at $19.2 million for FY2025, 64.03% up from the prior year.
  • Shares Issued hit $11.5 million in Q4 2025 for Guardant Health, up from $6.9 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $90.6 million in Q4 2023 to a low of -$3.2 million in Q3 2022.
  • Historically, Shares Issued has averaged $9.2 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest five-year swings in Shares Issued: surged 1230.2% in 2023 and later crashed 95.03% in 2024.
  • Year by year, Shares Issued stood at $4.4 million in 2021, then surged by 56.5% to $6.8 million in 2022, then soared by 1230.2% to $90.6 million in 2023, then plummeted by 95.03% to $4.5 million in 2024, then soared by 156.11% to $11.5 million in 2025.
  • Business Quant data shows Shares Issued for GH at $11.5 million in Q4 2025, $6.9 million in Q2 2025, and $768000.0 in Q1 2025.